InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
9
T+90 hit rate
58%
T+90 mean return
+57.3%
Across 36 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Feeley Kevin, Chief Financial Officer. Officer active across 2 companies, notably GeneDx Holdings Corp.. Aggregated, 49 reports have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €86k. History available since 29 April 2023. The latest transaction was filed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations49 total
7,197 sharesClass A Common StockSEC:0001944119-26-000031:0
760 sharesClass A Common StockSEC:0001944119-26-000031:1
2,106 sharesClass A Common StockSEC:0001944119-26-000031:2
863 sharesClass A Common StockSEC:0001944119-26-000031:3
2,462 sharesClass A Common StockSEC:0001944119-26-000029:0
1,266 sharesClass A Common StockSEC:0001944119-26-000029:1
15,262 shares0Class A Common StockSEC:0001944119-26-000011:0
15,262 shares0Class A Common StockSEC:0001944119-26-000011
1,246 shares@ US$32.677.2% of flowClass A Common StockSEC:0001415889-25-012579:0
753 shares0Class A Common StockSEC:0001415889-25-011696:0
1,246 shares@ US$32.677.2% of flowClass A Common StockSEC:0001415889-25-010536:0
16,250 shares0Class A Common StockSEC:0001415889-25-009194:0
402 shares@ US$90.05426.5% of flowClass A Common StockSEC:0001415889-25-008281:0
2,462 shares0Class A Common StockSEC:0001415889-25-007693:0
717 shares0Class A Common StockSEC:0001415889-25-006558:0
753 shares0Class A Common StockSEC:0001415889-25-002535:0
11,208 shares@ US$32.6768.7% of flowClass A Common StockSEC:0001415889-25-001306:0
319 shares@ US$75.07574.5% of flowClass A Common StockSEC:0001415889-25-000833:0
7,197 shares0Class A Common StockSEC:0001415889-24-029770:0
2,462 shares0Class A Common StockSEC:0001415889-24-029015:0
718 shares0Class A Common StockSEC:0001415889-24-028197:0
200 shares@ US$69.5752.6% of flowClass A Common StockSEC:0001415889-24-027662:0
753 shares0Class A Common StockSEC:0001415889-24-025838:0
7,197 shares0Class A Common StockSEC:0001415889-24-023619:0
2,462 shares0Class A Common StockSEC:0001415889-24-023264:0
25 of 49 declarations
About Feeley Kevin
Kevin Feeley is the Chief Financial Officer at GeneDx Holdings Corp. He is responsible for the company's financial management, including budgeting and financial analysis. With expertise in corporate finance, Kevin Feeley plays a key role in financial strategy and decision-making. His work contributes to the financial stability and growth of GeneDx Holdings Corp.
